APCER LIFE SCIENCES LTD.
Get an alert when APCER LIFE SCIENCES LTD. files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-12-31 (in 7mo)
Last filed for 2025-03-31
Confirmation statement due
2027-02-14 (in 9mo)
Last made up 2026-01-31
Watchouts
None on the register
Cash
£602K
Latest balance sheet
Net assets
£1M
Equity attributable
Employees
5
Average over period
Profit before tax
£2M
Period ending 2025-03-31
Name history
Renamed 1 time since incorporation
- APCER LIFE SCIENCES LTD. 2017-07-11 → present
- APCER PHARMA EUROPE LIMITED 2009-08-18 → 2017-07-11
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2025-03-31
| Metric | Trend | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Turnover | £18,436,001 | £18,511,653 | |
| Operating profit | £1,576,762 | £2,580,849 | |
| Profit before tax | £1,135,363 | £2,226,049 | |
| Net profit | £847,138 | £1,666,982 | |
| Cash | £493,470 | £602,110 | |
| Total assets less current liabilities | £6,086,200 | £3,954,115 | |
| Net assets | £2,261,614 | £1,328,596 | |
| Equity | £2,261,614 | £1,328,596 | |
| Average employees | 5 | 5 | |
| Wages | £391,165 | £360,883 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating margin | 8.6% | 13.9% | |
| Net margin | 4.6% | 9.0% | |
| Return on capital employed | 25.9% | 65.3% | |
| Current ratio | 1.67x | 1.38x | |
| Interest cover | 2.33x | 4.76x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on the going concern basis as the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for a period of at least 12 months from the date of signing of these financial statements. To assess the going concern assumption, the Company has prepared and considered trading and cash flow forecasts for the period covering at least 12 months from the date of approval of these financial statements. After having considered the information available to them to the date of signing the financial statements, the directors are satisfied that the company remains a going concern.”
Group structure
- APCER LIFE SCIENCES LTD. · parent
- APCER Life Sciences Limited 100%
- APCER Life Sciences India Limited 99.99%
Significant events
- “The Company's revenue and gross margin during the current year was marginally impacted. Reported operating profit was positively impacted by a reversal of provisions for doubtful debts of £1,538,146 (2024: £4,157), partially offset by the impairment of an investment in a project.”
- “In May 2023, the company refinanced its facilities with Clydesdale Bank Plc. The bank loans falling due within one year includes an amount of £Nil (2024: £Nil) relating to the revolving credit facility. However, there is an outstanding fee of £15,167 (2024: £Nil), which was paid subsequent to the year-end. This facility is secured in favour of Clydesdale Bank Plc over certain assets of the APCER group.”
- “In May 2023, the company restructured its financing with Clydesdale Bank Plc, settling the old arrangements. Facility A, of which £3,900,000 is outstanding as at 31 March 2025 (31 March 2024: £5,100,000), is payable in quarterly instalments until May 2028 and bears interest at a rate that fluctuates in line with the SONIA rate.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 3 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| KACKER, Vineet, Dr | Director | 2009-08-21 | Aug 1966 | British |
| KILEY, John Francis | Director | 2015-02-02 | May 1959 | American |
| MENON, Divya Ravindra | Director | 2020-09-14 | Jan 1983 | Indian |
| MENON, Ravindra Narayan | Director | 2009-08-21 | Apr 1950 | Indian |
| MENON, Tejus Ravindra | Director | 2012-05-31 | Jun 1985 | Indian |
| MENON, Thiruthipalli Gopal | Director | 2015-02-02 | Jul 1964 | Indian |
Show 3 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BHATTACHARYA, Sugata | Director | 2009-08-18 | 2014-10-24 |
| NEMETH, Kornelia | Director | 2009-08-21 | 2011-03-15 |
| SRINET, Navita | Director | 2015-02-02 | 2017-04-10 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Apcer Life Sciences Holding Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-03-20 | Active |
| Ravindra Narayan Menon | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2019-03-20 |
Filing timeline
Last 20 of 113 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-02-02 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2026-02-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-12-23 | AA | accounts | Accounts with accounts type full | |
| 2025-02-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-12-13 | AA | accounts | Accounts with accounts type full | |
| 2024-02-14 | CH01 | officers | Change person director company with change date | |
| 2024-02-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-12-29 | AA | accounts | Accounts with accounts type full | |
| 2023-05-10 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-02-14 | CH01 | officers | Change person director company with change date | |
| 2023-02-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-01-03 | AA | accounts | Accounts with accounts type full | |
| 2022-02-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-12-30 | AA | accounts | Accounts with accounts type full | |
| 2021-04-03 | AA | accounts | Accounts with accounts type full | |
| 2021-03-12 | CH01 | officers | Change person director company with change date | |
| 2021-03-11 | CH01 | officers | Change person director company with change date | |
| 2021-02-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-09-29 | AP01 | officers | Appoint person director company with name date | |
| 2020-03-06 | AD01 | address | Change registered office address company with date old address new address |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31